Biochem/physiol Actions

Cell permeable: no

Reversible: no

Primary TargetTLR7 (toll-like receptor 7)

Product does not compete with ATP.

General description

An imidazoquinoline compound that acts as a potent immunomodulator and displays anti-angiogenic, anti-viral and anti-inflammatory properties. Reported to bind to the cell surface receptor, TLR7 (toll-like receptor 7), and induce the secretion of several pro-inflammatory cytokines and chemokines both in vitro and in vivo.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.

Majewski, S., et al. 2005. Int. J. Dermatol.44, 14.Gibson, S.J., et al. 2002. Cell. Immunol.218, 74.Hemmi, H., et al. 2002. Nat. Immunol.3, 196.Megyeri, K., et al. 1995. Mol. Cell. Biol.15, 2207.

Packaging

Packaged under inert gas

250 mg in Plastic ampoule

Preparation Note

warming to 60°C is required for complete solubilization.

Reconstitution

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. Upon thawing, warming may be required to resolubilize precipitated product.

Warning

Toxicity: Toxic (F)